Advanced hepatocellular carcinoma treatment strategies: Are transarterial approaches leading the way?

doi:10.4251/wjgo.v17.i1.99834

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (203)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

HTML

143

Sum=150

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=43

Jan 15, 2025 (publication date) through Dec 22, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastrointest Oncol. Jan 15, 2025; 17(1): 99834
Published online Jan 15, 2025. doi: 10.4251/wjgo.v17.i1.99834

Advanced hepatocellular carcinoma treatment strategies: Are transarterial approaches leading the way?

Stefan Patauner, Giovanni Scotton, Francesca Notte, Antonio Frena

Stefan Patauner, Giovanni Scotton, Francesca Notte, Antonio Frena, Department of General and Pediatric Surgery, Bolzano Central Hospital - SABES, Bolzano 39100, Trentino-Alto Adige, Italy

Co-first authors: Stefan Patauner and Giovanni Scotton.

Author contributions: Frena A designed the overall concept of the manuscript and revised the manuscript; Patauner S and Scotton G equally contributed to the design, review of the literature and writing of the manuscript; Notte F contributed to the review of the literature and editing of the manuscript; All authors contributed to this paper.

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Antonio Frena, MD, PhD, Surgeon, Department of General and Pediatric Surgery, Bolzano Central Hospital - SABES, Via Boehler 5, Bolzano 39100, Trentino-Alto Adige, Italy. antonio.frena@sabes.it

Received: July 31, 2024
Revised: September 20, 2024
Accepted: September 25, 2024
Published online: January 15, 2025
Processing time: 133 Days and 22.1 Hours

Core Tip

Core Tip: The treatment landscape for hepatocellular carcinoma (HCC) is various, including surgical resection, ablation, transplantation, transarterial, and systemic therapies. Each modality is selected based on tumor characteristics, liver function, and patient performance status. This editorial explores the role of hepatic arterial infusion chemotherapy and its combination strategies for advanced HCC, highlighting its potential advantages and advocating for its broader acceptance based on recent meta-analysis findings.